Market Research Report : OTC drug market in India 2012


Published on

For the complete report, get in touch with us at :

Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.

The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.

An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures

The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.

A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.

The competition section gives overview of pharmaceutical companies in the country operating in the OTC product industry. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. It also incorporates the recent developments in the OTC drug industry.

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Market Research Report : OTC drug market in India 2012

  1. 1. Insert Cover Image using Slide Master View Do not distortOTC Drug Market ‐OTC Drug Market IndiaJune 2012
  2. 2. Executive Summary  India currently ranks eleventh in the global Over‐the‐counter (OTC) drug market Market  OTC drug market in India is valued at INR XX unit in 20‐‐  The market is expected to grow at a CAGR of m% from 20‐‐ to 20‐‐ Drivers: Challenges:  Rising consumer confidence in OTC   Low penetration in rural areas products  Preference of home remedies  Switch of prescription drugs to OTC   Competitive market Drivers and  widens growth opportunity of OTC Challenges  Time consuming clinical trial procedures  Increasing focus on brand building  Booming retail growth  Changing demographics  Lower price control Public Players Private Players Competition Player 1; Player 2; Player 3; Player 4; Player 5; Player  Payer 1; player 2; Player 3; Player 4 6; Player 7; Player 8; Player 9; Player 10; Player11 OTC DRUG MARKET IN INDIA 2012.PPT 2
  3. 3. Global OTC drug market is expected to witness a huge growth over the coming yearsGlobal Market – Overview  Market Size and Growth• OTC pharmaceutical is one of the largest segments of  INR XX the overall pharma market p 8 M% A5 A6 A2 A3 A4• The market has a size of INR A1 unit in 20‐‐ and is  6 A1 expected to grow at a CAGR of m % from 20‐‐ to 20‐‐ 4• Cough and cold medicines are the leading contributor in  2 the global market, comprising almost p% of the total  0 market 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e• Major growth is expected to come from the Asia‐Pacific  Note: Revenue fluctuations caused due to the changes in exchange rate region, which is the largest contributor to global sales  region, which is the largest contributor to global sales OTC Drug Distribution – 20‐‐ and accounts for q% of the global market• In 20‐‐,pharmacy retail chains formed the major share of  A the distribution channel in the global OTC pharma  A% B market, accounting for r% of the total value C• A large number of drugs are shifting from prescription  B% to OTC, thus drives the market extensively C% OTC DRUG MARKET IN INDIA 2012.PPT 3
  4. 4. Increasing amount of consumer confidence in OTC products  is driving the Indian market Indian Market – Overview  Market Size and Growth • Over‐the‐counter drug market in India has a huge  INR YY potential 200 X6 y% X5 150 X4 • Indian OTC market had a size of INR X bn in 20‐‐ and  X3 X2 X1 is expected to grow at a CAGR of y% from 20‐‐ to 20‐‐ 100 50 • India currently ranks eleventh in the global OTC India currently ranks eleventh in the global OTC  market and it is estimated that it will reach ninth  0 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e position within next five years • Sales channels for OTC drugs are extensive, as they  Sa es c a e s o O C d ugs a e e te s e, as t ey OTC Drug Distribution – 20‐‐ do not require a drug license and can be sold by non  D3% D1 chemists as well D4% D2 • Vitamins and minerals segments are the most  D2% D3 popular segments, with a share of around Y% D4 D1%Source: OTC DRUG MARKET IN INDIA 2012.PPT 4
  5. 5. Drivers & Challenges – Summary Drivers Di Challenges Rising consumer confidence in OTC  products Low penetration in rural areas Switch of prescription drugs to OTC  p p g widens growth opportunity of OTC Preference of home remedies  Booming retail growth Competitive market Increasing focus on brand building Time consuming clinical trial  Ti i li i l t i l procedures Changing demographics Low price control OTC DRUG MARKET IN INDIA 2012.PPT 5
  6. 6. Government Initiatives – Summary  Reduction in drug prices  Government Initiatives I iti ti Other Initiatives Other Initiatives Changes in tax structure Changes in tax structure OTC DRUG MARKET IN INDIA 2012.PPT 6
  7. 7. Major Companies – Summary Net Profit (INR mn)4,000 Size of the Bubble represents Total Assets in 3,500 INR units INR units3,0002,5002,0001,5001 5001,000 500 Revenue 0 (INR mn) 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 Company A Company B Company C OTC DRUG MARKET IN INDIA 2012.PPT 7
  8. 8. Public: Domestic Company – Company A (1/4)Company Information Offices and Centres – India  Company ACorporate Address Address Line 1 Address Line 2Tel No. +91 xx xxxxxxxx Fax No. +91 xx xxxxxxxx  XWebsite www.a.comYear of IncorporationYear of Incorporation 19‐‐ 19Ticker Symbol xxxStock Exchange NNN Head OfficeProducts and Services Key PeopleCategory Products/ServicesHealthcare  Nutritional drinks, pharmaceuticals,  Name N Designation D i iManagement OTC Person A Chairman, M.D.F&B Drinks and cola Person B GM of Finance Person c President‐ OTC Division Person D Senior V.P. Sales & Marketing OTC DRUG MARKET IN INDIA 2012.PPT 8
  9. 9. Public: Domestic Company – Company A (2/4) Financial Snapshot i i lS h Key Ratios K i Total Income y‐o‐y change INR units INR units  Particulars  20‐‐ 20‐‐ 20‐‐ 20‐‐ (20‐‐ ‐ ‐‐) Net Profit / Loss Profitability Ratios2.0 s 20 t r q Operating Margin1.515 0 Net Margin1.0 n Profit Before Tax Margin p ‐20 Return on Equity0.5 m o Return on Capital Employed0.0 ‐40 Return on Working Capital 20‐‐ 20‐‐ 20‐‐ 20‐‐ Return on Assets Financial Summary  Return on Fixed Assets Cost Ratios • The company earned a net profit of INR q units in FY 20‐‐, as  Operating costs (% of Sales) compared to net profit of INR r units in FY 20‐‐ Administration costs (% of  • The company reported total income of  INR p units in FY 20‐‐,  Sales) registering an increase of t per cent over FY 20‐‐ registering an increase of t per cent over FY 20 Interest costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios • The company earned an operating margin of f per cent in FY 20‐‐, a  Current Ratio decrease of g percentage points over FY 20‐‐ Cash Ratio • The company reported debt to equity ratio of h in FY 20‐‐, an  Leverage Ratios increase of z per cent over FY 20‐‐ Debt to Equity Ratio Debt to Capital Ratio b i l iKey Financial Performance Indicators Interest Coverage Ratio Indicators Value (dd/mm/20‐‐) Efficiency Ratios Market Capitalization (INR) Fixed Asset Turnover Asset Turnover Total Enterprise Value (INR) Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved Decline OTC DRUG MARKET IN INDIA 2012.PPT 9
  10. 10. Public: Domestic Company – Company A (3/4)Key Business Segments Key Geographic Segments x y z 100% A 100 80 x 60 x x x 40 Company A has been solely  operating in India y 20 z y z y z y z 0 20‐‐ 20‐‐ 20‐‐ 20‐‐ 20‐‐Business Highlights Description  i i News • Company A is an integrated research based company that produces a wide range of generic medicinesOverview • Serves customers in over 100 countries with manufacturing facilities in several countriesOTC • Has been operating in the OTC industry for the past 12 years • Is making consistent effort for continual improvement in rural areas with respect to accessibility of Key Initiatives medicines OTC DRUG MARKET IN INDIA 2012.PPT 10
  11. 11. Public: Domestic Company – Company A (4/4)OTC ProductsOTC P d tProduct Category OTC ProductsPain Management Product A, Product BCongestion  Product C, Product DManagementHealthcare  Product E, Product FManagement OTC DRUG MARKET IN INDIA 2012.PPT 11
  12. 12. Thank you for the attentionThe OTC Drug Market – India report is part of Research on India’s Healthcare Series.For more detailed information or customized research requirements please contact:Phone: +91 33 4064 6214 91 33 4064 6214E‐Mail: sales@netscribes.comFollow us on:About NetscribesNetscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &  g g f g p y p p fbusiness research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives.Disclaimer: This report is published for general information only. Although high standards have been used in the preparation,  Netscribes isDisclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. OTC DRUG MARKET IN INDIA 2012.PPT 12